Clarithromycin Leads to Long-Term Survival and Cost Benefit in Ventilator-Associated Pneumonia and Sepsis

Increasing numbers of admissions for sepsis impose a heavy burden on health care systems worldwide, while novel therapies have proven both expensive and ineffective. We explored the long-term mortality and hospitalization costs after adjunctive therapy with intravenous clarithromycin in ventilator-a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antimicrob Agents Chemother
Asıl Yazarlar: Tsaganos, Thomas, Raftogiannis, Maria, Pratikaki, Maria, Christodoulou, Sofia, Kotanidou, Anastasia, Papadomichelakis, Evangelos, Armaganidis, Apostolos, Routsi, Christina, Giamarellos-Bourboulis, Evangelos J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2016
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879428/
https://ncbi.nlm.nih.gov/pubmed/27044546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02974-15
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller